These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 10810289)

  • 1. Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6.
    Bond JJ; Meka S; Baxter RC
    J Endocrinol; 2000 May; 165(2):253-60. PubMed ID: 10810289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit.
    Twigg SM; Baxter RC
    J Biol Chem; 1998 Mar; 273(11):6074-9. PubMed ID: 9497324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Column chromatographic characterization of complex formation of pro-IGF-II isoforms with acid labile subunit and IGF-binding proteins associated with non-islet cell tumour induced hypoglycaemia.
    van Veggel KM; Huits RM; Donker GH; Lentjes EG; van Doorn J
    Growth Horm IGF Res; 2014 Dec; 24(6):233-8. PubMed ID: 25174810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Various components of the insulin-like growth factor system in tumor tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients.
    de Bont JM; van Doorn J; Reddingius RE; Graat GH; Passier MM; den Boer ML; Pieters R
    Int J Cancer; 2008 Aug; 123(3):594-600. PubMed ID: 18478565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of insulin-like growth factor II (IGF-II) with multiple plasma proteins: high affinity binding of plasminogen to IGF-II and IGF-binding protein-3.
    Oesterreicher S; Blum WF; Schmidt B; Braulke T; Kübler B
    J Biol Chem; 2005 Mar; 280(11):9994-10000. PubMed ID: 15642732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma.
    Hoekman K; van Doorn J; Gloudemans T; Maassen JA; Schuller AG; Pinedo HM
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):247-53. PubMed ID: 10468998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular distribution and ontogeny of insulin-like growth factors (IGFs) and IGF binding protein messenger RNAs and peptides in developing rat pancreas.
    Hill DJ; Hogg J; Petrik J; Arany E; Han VK
    J Endocrinol; 1999 Feb; 160(2):305-17. PubMed ID: 9924201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A major portion of the 150-kilodalton insulin-like growth factor-binding protein (IGFBP) complex in adult rat serum contains unoccupied, proteolytically nicked IGFBP-3 that binds IGF-II preferentially.
    Lee CY; Rechler MM
    Endocrinology; 1995 Feb; 136(2):668-78. PubMed ID: 7530649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-I, IGF-II, 'free' IGF-I and IGF-binding proteins-2 to -6 during high-dose oestrogen treatment in constitutionally tall girls.
    Rooman RP; De Beeck LO; Martin M; Van Doorn J; Mohan S; Du Caju MV
    Eur J Endocrinol; 2002 Jun; 146(6):823-9. PubMed ID: 12039703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.
    Kricker JA; Towne CL; Firth SM; Herington AC; Upton Z
    Endocrinology; 2003 Jul; 144(7):2807-15. PubMed ID: 12810534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A purified bovine serum albumin preparation contains an insulin-like growth factor (IGF) binding protein-3 fragment that forms ternary complexes selectively with IGF-II and the acid-labile subunit.
    Twigg SM; Hardman KV; Baxter RC
    Growth Horm IGF Res; 2000 Aug; 10(4):215-23. PubMed ID: 11032705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6.
    Bach LA; Hsieh S; Sakano K; Fujiwara H; Perdue JF; Rechler MM
    J Biol Chem; 1993 May; 268(13):9246-54. PubMed ID: 7683646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D.
    Claussen M; Kübler B; Wendland M; Neifer K; Schmidt B; Zapf J; Braulke T
    Endocrinology; 1997 Sep; 138(9):3797-803. PubMed ID: 9275067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia.
    Holt RI; Teale JD; Jones JS; Quin JD; McGregor AM; Miell JP
    Growth Horm IGF Res; 1998 Dec; 8(6):447-54. PubMed ID: 10985756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
    McCarthy TL; Casinghino S; Centrella M; Canalis E
    J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children.
    Mandel SH; Moreland E; Rosenfeld RG; Gargosky SE
    Endocrine; 1997 Dec; 7(3):351-60. PubMed ID: 9657073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGFBPs modulate IGF-I- and high glucose-controlled growth of human retinal endothelial cells.
    Giannini S; Cresci B; Pala L; Ciucci A; Franchini A; Manuelli C; Fujita-Yamaguchi Y; Cappugi P; Zonefrati R; Rotella CM
    J Endocrinol; 2001 Nov; 171(2):273-84. PubMed ID: 11691647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor binding protein-3: factors affecting binary and ternary complex formation.
    Holman SR; Baxter RC
    Growth Regul; 1996 Mar; 6(1):42-7. PubMed ID: 8717449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.